Literature DB >> 16600411

OMICS-driven biomarker discovery in nutrition and health.

Martin Kussmann1, Frédéric Raymond, Michael Affolter.   

Abstract

While traditional nutrition research has dealt with providing nutrients to nourish populations, it nowadays focuses on improving health of individuals through diet. Modern nutritional research is aiming at health promotion and disease prevention and on performance improvement. As a consequence of these ambitious objectives, the disciplines "nutrigenetics" and "nutrigenomics" have evolved. Nutrigenetics asks the question how individual genetic disposition, manifesting as single nucleotide polymorphisms, copy-number polymorphisms and epigenetic phenomena, affects susceptibility to diet. Nutrigenomics addresses the inverse relationship, that is how diet influences gene transcription, protein expression and metabolism. A major methodological challenge and first pre-requisite of nutrigenomics is integrating genomics (gene analysis), transcriptomics (gene expression analysis), proteomics (protein expression analysis) and metabonomics (metabolite profiling) to define a "healthy" phenotype. The long-term deliverable of nutrigenomics is personalised nutrition for maintenance of individual health and prevention of disease. Transcriptomics serves to put proteomic and metabolomic markers into a larger biological perspective and is suitable for a first "round of discovery" in regulatory networks. Metabonomics is a diagnostic tool for metabolic classification of individuals. The great asset of this platform is the quantitative, non-invasive analysis of easily accessible human body fluids like urine, blood and saliva. This feature also holds true to some extent for proteomics, with the constraint that proteomics is more complex in terms of absolute number, chemical properties and dynamic range of compounds present. Apart from addressing the most complex "-ome", proteomics represents the only platform that delivers not only markers for disposition and efficacy but also targets of intervention. The Omics disciplines applied in the context of nutrition and health have the potential to deliver biomarkers for health and comfort, reveal early indicators for disease disposition, assist in differentiating dietary responders from non-responders, and, last but not least, discover bioactive, beneficial food components. This paper reviews the state-of-the-art of the three Omics platforms, discusses their implication in nutrigenomics and elaborates on applications in nutrition and health such as digestive health, allergy, diabetes and obesity, nutritional intervention and nutrient bioavailability. Proteomic developments, applications and potential in the field of nutrition have been specifically addressed in another review issued by our group.

Entities:  

Mesh:

Year:  2006        PMID: 16600411     DOI: 10.1016/j.jbiotec.2006.02.014

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  48 in total

1.  MUC5B Is the predominant mucin glycoprotein in chronic otitis media fluid.

Authors:  Diego Preciado; Samita Goyal; Michael Rahimi; Alan M Watson; Kristy J Brown; Yetrib Hathout; Mary C Rose
Journal:  Pediatr Res       Date:  2010-09       Impact factor: 3.756

Review 2.  Mass spectrometry based proteomics in urine biomarker discovery.

Authors:  Dan Theodorescu; Harald Mischak
Journal:  World J Urol       Date:  2007-08-17       Impact factor: 4.226

3.  Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics.

Authors:  L Katie Crosley; Susan J Duthie; Abigael C Polley; Freek G Bouwman; Carolin Heim; Francis Mulholland; Graham Horgan; Ian T Johnson; Edwin C Mariman; Ruan M Elliott; Hannelore Daniel; Baukje de Roos
Journal:  Genes Nutr       Date:  2009-04-29       Impact factor: 5.523

4.  The challenges for molecular nutrition research 1: linking genotype to healthy nutrition.

Authors:  Christine M Williams; Jose M Ordovas; Dennis Lairon; John Hesketh; Georg Lietz; Mike Gibney; Ben van Ommen
Journal:  Genes Nutr       Date:  2008-07       Impact factor: 5.523

5.  The challenges for molecular nutrition research 2: quantification of the nutritional phenotype.

Authors:  Ben van Ommen; Jaap Keijer; Robert Kleemann; Ruan Elliott; Christian A Drevon; Harry McArdle; Mike Gibney; Michael Müller
Journal:  Genes Nutr       Date:  2008-06-25       Impact factor: 5.523

6.  Proteome differences associated with fat accumulation in bovine subcutaneous adipose tissues.

Authors:  Yong Mei Zhao; Urmila Basu; Michael V Dodson; John A Basarb; Le Luo Guan
Journal:  Proteome Sci       Date:  2010-03-18       Impact factor: 2.480

7.  The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker.

Authors:  Gian Paolo Fadini; Mattia Albiero; Renato Millioni; Nicol Poncina; Mauro Rigato; Rachele Scotton; Federico Boscari; Enrico Brocco; Giorgio Arrigoni; Gianmarco Villano; Cristian Turato; Alessandra Biasiolo; Patrizia Pontisso; Angelo Avogaro
Journal:  Diabetologia       Date:  2014-06-25       Impact factor: 10.122

8.  Identification of biochemical differences between different forms of male infertility by nuclear magnetic resonance (NMR) spectroscopy.

Authors:  Varshini Jayaraman; Soumita Ghosh; Arjun Sengupta; Sudha Srivastava; H M Sonawat; Pratap Kumar Narayan
Journal:  J Assist Reprod Genet       Date:  2014-06-26       Impact factor: 3.412

9.  Connecting extracellular metabolomic measurements to intracellular flux states in yeast.

Authors:  Monica L Mo; Bernhard O Palsson; Markus J Herrgård
Journal:  BMC Syst Biol       Date:  2009-03-25

10.  MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides.

Authors:  Xu Yang; Iulia M Lazar
Journal:  BMC Cancer       Date:  2009-03-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.